These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 31351996)

  • 1. The role of dopamine in the pathogenesis of GBA1-linked Parkinson's disease.
    Burbulla LF; Krainc D
    Neurobiol Dis; 2019 Dec; 132():104545. PubMed ID: 31351996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocerebrosidase deficiency in dopaminergic neurons induces microglial activation without neurodegeneration.
    Soria FN; Engeln M; Martinez-Vicente M; Glangetas C; López-González MJ; Dovero S; Dehay B; Normand E; Vila M; Favereaux A; Georges F; Lo Bianco C; Bezard E; Fernagut PO
    Hum Mol Genet; 2017 Jul; 26(14):2603-2615. PubMed ID: 28520872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A modulator of wild-type glucocerebrosidase improves pathogenic phenotypes in dopaminergic neuronal models of Parkinson's disease.
    Burbulla LF; Jeon S; Zheng J; Song P; Silverman RB; Krainc D
    Sci Transl Med; 2019 Oct; 11(514):. PubMed ID: 31619543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocerebrosidase gene therapy prevents α-synucleinopathy of midbrain dopamine neurons.
    Rocha EM; Smith GA; Park E; Cao H; Brown E; Hayes MA; Beagan J; McLean JR; Izen SC; Perez-Torres E; Hallett PJ; Isacson O
    Neurobiol Dis; 2015 Oct; 82():495-503. PubMed ID: 26392287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson's disease.
    Burbulla LF; Song P; Mazzulli JR; Zampese E; Wong YC; Jeon S; Santos DP; Blanz J; Obermaier CD; Strojny C; Savas JN; Kiskinis E; Zhuang X; Krüger R; Surmeier DJ; Krainc D
    Science; 2017 Sep; 357(6357):1255-1261. PubMed ID: 28882997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of β-Glucocerebrosidase Reduces Pathological α-Synuclein and Restores Lysosomal Function in Parkinson's Patient Midbrain Neurons.
    Mazzulli JR; Zunke F; Tsunemi T; Toker NJ; Jeon S; Burbulla LF; Patnaik S; Sidransky E; Marugan JJ; Sue CM; Krainc D
    J Neurosci; 2016 Jul; 36(29):7693-706. PubMed ID: 27445146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocerebrosidase Gene Therapy Induces Alpha-Synuclein Clearance and Neuroprotection of Midbrain Dopaminergic Neurons in Mice and Macaques.
    Sucunza D; Rico AJ; Roda E; Collantes M; González-Aseguinolaza G; Rodríguez-Pérez AI; Peñuelas I; Vázquez A; Labandeira-García JL; Broccoli V; Lanciego JL
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34062940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulation of mitochondria-lysosome contacts by GBA1 dysfunction in dopaminergic neuronal models of Parkinson's disease.
    Kim S; Wong YC; Gao F; Krainc D
    Nat Commun; 2021 Mar; 12(1):1807. PubMed ID: 33753743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The lysosomal β-glucocerebrosidase strikes mitochondria: implications for Parkinson's therapeutics.
    Rubilar JC; Outeiro TF; Klein AD
    Brain; 2024 Aug; 147(8):2610-2620. PubMed ID: 38437875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.
    Perfeito R; Cunha-Oliveira T; Rego AC
    Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synaptic, Mitochondrial, and Lysosomal Dysfunction in Parkinson's Disease.
    Nguyen M; Wong YC; Ysselstein D; Severino A; Krainc D
    Trends Neurosci; 2019 Feb; 42(2):140-149. PubMed ID: 30509690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Converging roles of ion channels, calcium, metabolic stress, and activity pattern of Substantia nigra dopaminergic neurons in health and Parkinson's disease.
    Duda J; Pötschke C; Liss B
    J Neurochem; 2016 Oct; 139 Suppl 1(Suppl Suppl 1):156-178. PubMed ID: 26865375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acid ceramidase inhibition ameliorates α-synuclein accumulation upon loss of GBA1 function.
    Kim MJ; Jeon S; Burbulla LF; Krainc D
    Hum Mol Genet; 2018 Jun; 27(11):1972-1988. PubMed ID: 29579237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
    Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M
    Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Cholesterol in α-Synuclein and Lewy Body Pathology in GBA1 Parkinson's Disease.
    García-Sanz P; M F G Aerts J; Moratalla R
    Mov Disord; 2021 May; 36(5):1070-1085. PubMed ID: 33219714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melanin and Neuromelanin: Linking Skin Pigmentation and Parkinson's Disease.
    Krainc T; Monje MHG; Kinsinger M; Bustos BI; Lubbe SJ
    Mov Disord; 2023 Feb; 38(2):185-195. PubMed ID: 36350228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The L444P Gba1 mutation enhances alpha-synuclein induced loss of nigral dopaminergic neurons in mice.
    Migdalska-Richards A; Wegrzynowicz M; Rusconi R; Deangeli G; Di Monte DA; Spillantini MG; Schapira AHV
    Brain; 2017 Oct; 140(10):2706-2721. PubMed ID: 28969384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective loss of glucocerebrosidase activity in sporadic Parkinson's disease and dementia with Lewy bodies.
    Chiasserini D; Paciotti S; Eusebi P; Persichetti E; Tasegian A; Kurzawa-Akanbi M; Chinnery PF; Morris CM; Calabresi P; Parnetti L; Beccari T
    Mol Neurodegener; 2015 Mar; 10():15. PubMed ID: 25881142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo imaging of neuromelanin in Parkinson's disease using 18F-AV-1451 PET.
    Hansen AK; Knudsen K; Lillethorup TP; Landau AM; Parbo P; Fedorova T; Audrain H; Bender D; Østergaard K; Brooks DJ; Borghammer P
    Brain; 2016 Jul; 139(Pt 7):2039-49. PubMed ID: 27190023
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Skrahin A; Horowitz M; Istaiti M; Skrahina V; Lukas J; Yahalom G; Cohen ME; Revel-Vilk S; Goker-Alpan O; Becker-Cohen M; Hassin-Baer S; Svenningsson P; Rolfs A; Zimran A
    Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000225
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.